Benedicto Crespo-Facorro, MD, PhD

  • 6Articles
  • 28.6KReads1
  • 2006–2022Active
  • 27Collaborators
  • 118Citations2

About

Benedicto Crespo-Facorro, MD, PhD, is affiliated with the Department of Psychiatry at University Hospital Virgen del Rocío, the Seville Biomedical Research Center (IBIS), and the Network for Research in Mental Health (CIBERSAM) in Seville, Spain. Since 2006, Crespo-Facorro has published extensively on neuropsychiatric topics, focusing on schizophrenia and schizoaffective disorders, including clinical trials comparing antipsychotic treatments and studies on neurocognitive and metabolic effects in first-episode psychosis patients. Recent work also addresses mental health implications related to COVID-19 and its treatments. Crespo-Facorro frequently collaborates with researchers such as Obdulia Martínez-García and Jose Luis Vázquez-Barquero.

Publications

PCC
Attempted Suicide, Dexamethasone, and COVID-19
Case Report

Attempted Suicide, Dexamethasone, and COVID-19

September 1, 2022

A patient with COVID-19 and pneumonia, who was administered dexamethasone in the hospital, attempted suicide after discharge.
, , , et al
JCP
Original Research

Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study

April 27, 2016

, , , et al
JCP
Original Research

Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison

April 21, 2009

, , , et al
JCP
Original Research

A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone

November 15, 2007

, , , et al
JCP
Original Research

A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.

October 16, 2006

, , , et al
JCP
Original Research

Attenuation of Antipsychotic-Induced Weight Gain With Early Behavioral Intervention in Drug-Naive First-Episode Psychosis Patients: A Randomized Controlled Trial

August 15, 2006

, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe